Jan 15, 2025 09:15AM
Jan 15, 2025 09:15AM
Dec 19, 2024 09:15AM
Dec 9, 2024 09:00AM
Aug 21, 2024 09:02AM
Aug 21, 2024 09:00AM
Jul 24, 2024 09:05AM TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today
Jul 24, 2024 09:05AM
Jul 22, 2024 09:01AM
Jul 22, 2024 09:00AM
Jun 17, 2024 09:03AM
Jun 17, 2024 09:00AM
May 21, 2024 09:00AM
May 21, 2024 09:00AM MyMD Pharmaceuticals Secures Strategic Investments
Mar 5, 2024 09:15AM
Mar 5, 2024 09:15AM
Feb 13, 2024 11:45AM
Feb 13, 2024 11:45AM
Dec 29, 2023 12:49PM
Dec 29, 2023 12:45PM
Dec 6, 2023 09:17AM MyMD Pharmaceuticals (MYMD) Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
Dec 6, 2023 09:15AM
Oct 4, 2023 07:30AM
Aug 14, 2023 08:31AM
Aug 14, 2023 08:30AM
Jul 31, 2023 09:27AM
Jul 31, 2023 09:00AM
Apr 12, 2023 08:30AM MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan
Mar 2, 2023 08:33AM
Mar 2, 2023 08:30AM
Feb 28, 2023 08:30AM
Feb 21, 2023 08:45AM
Feb 21, 2023 08:45AM
Dec 6, 2022 08:00AM
Nov 17, 2022 08:00AM MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress
Nov 14, 2022 08:03AM
Nov 14, 2022 08:00AM
Aug 30, 2022 08:31AM
Aug 30, 2022 08:30AM
Aug 3, 2022 09:46AM
Aug 3, 2022 09:45AM
Jul 26, 2022 07:33AM MyMD Pharmaceuticals (MYMD) Advances Phase 2 Multi-Center Clinical Trial of MYMD-1
Jul 26, 2022 07:30AM
Jul 12, 2022 09:30AM
Jul 12, 2022 09:30AM
Jun 21, 2022 10:30AM
Jun 21, 2022 10:30AM
Apr 12, 2022 09:30AM
Apr 12, 2022 09:30AM MyMD Pharmaceuticals’ Lead Compound MYMD-1 Demonstrates Superior Anti-inflammatory Effects over Top-Selling Therapies in a Pivotal Preclinical Model of Rheumatoid Arthritis
Apr 5, 2022 09:17AM

325,738 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All